Rita E. Serda, Ph.D.
Research Assistant Professor
Department of Internal Medicine, Division of Molecular Medicine
Department of Chemical & Biological Engineering
The University of New Mexico
Beyond the need for preventative vaccines, there is a global need for therapeutic cancer vaccines that are able to overcome cancer-related suppression of cell-mediated immune responses and guide specific immune responses against cells expressing tumor-associated neoantigens. Dr. Serda’s research projects include a unique cell processing method to transform cancer cells into stable, pathogen mimics, creating potent personalized cancer vaccines and optimization of Immunogenic nanoparticles loaded with cancer antigens and adjuvant and immunogenic cell death inducing chemotherapeutics and adjuvants.
PENDING U.S. PATENT APPLICATIONS (UNM-AFFILIATED)
Cationic Liposomes for Cancer Immunotherapy
Silicified Cell Replicas, Methods of Making, and Methods of Using
Liposomal Coated Nanoparticles for Immunotherapy Applications
A High Capacity Platform for Immunogenic Cancer Cell Death
Silicified Cell Replicas, Methods of Making, and Methods of Using